市場調查報告書
商品編碼
1561465
2024-2032 年按類型、材料、應用、最終用戶和地區分類的手術縫合線市場報告Surgical Sutures Market Report by Type, Material, Application, End User, and Region 2024-2032 |
2023年全球手術縫線IMARC Group規模達51億美元。先進縫合材料的開發、技術的快速進步、消費者偏好轉向微創手術(MIS)、消費者人均收入的膨脹以及整容手術的迅速普及是推動市場成長的一些因素。
慢性病盛行率不斷上升
在全球範圍內,慢性病的盛行率正以前所未有的速度增加,這進一步增加了對手術縫線的需求。根據世界衛生組織 (WHO) 統計,每年約有 4,100 萬人死於非傳染性疾病,相當於全球死亡人數的 74%。肥胖、糖尿病、心血管疾病和癌症的盛行率不斷上升,增加了對手術介入的需求,這進一步刺激了市場成長。根據國際糖尿病聯盟 (IDF) 的數據,到 2045 年,大約有 7.83 億人將患有糖尿病。由於人口老化和生活方式的改變等因素,這些情況變得更加常見,對外科手術的需求不斷增加。因此,對手術縫合線的需求增加,這對於術後閉合傷口至關重要。
先進縫合材料的開發
手術縫合線市場的最新發展徹底改變了傷口閉合技術,這進一步支持了市場的成長。主要市場參與者正在開發與人體更相容的現代縫合線,以盡量減少感染風險並促進快速癒合。例如,2023 年5 月,麻省理工學院(MIT) 的一個工程師團隊開發了「智慧」縫合線,有可能使接受手術的克隆氏症患者受益,並且還可以在藥物輸送、感知發炎和細胞方面得到應用。這些進步有助於改善患者的治療效果,並滿足外科醫生不斷變化的需求,標誌著外科護理領域的重大飛躍。
整容手術迅速普及
消費者人均收入的成長大大增加了尋求美容的需求,進一步增加了對整容手術的需求,這是推動市場成長的主要因素。根據國際美容整形外科學會 (ISAPS) 2020 年統計,2019 年全球進行了超過 2400 萬例非手術和手術美容手術。美學效果並確保最小化疤痕。在社會壓力、媒體影響力和自我完善願望的推動下,化妝品產業蓬勃發展,導致外科手術數量激增。
IMARC Group提供了每個細分市場的主要趨勢的分析,以及 2024-2032 年全球、區域和國家層面的預測。我們的報告根據類型、材料、應用和最終用戶對市場進行了分類。
可吸收縫線佔大部分市場佔有率
該報告根據類型提供了詳細的市場細分和分析。這包括可吸收縫線和不可吸收縫線。根據該報告,可吸收縫線佔最大部分。
可吸收縫線領域的推動因素是對微創外科手術的需求不斷成長,以及對可吸收材料的日益青睞,因為它們能夠隨著時間的推移在體內無害地分解,從而無需拆線。此外,技術進步導致抗張強度、靈活性和生物相容性增強的可吸收縫線的開發,進一步推動了這一領域的成長。例如,2023年5月,開發了一種新型奈米複合塗層,可以抑制生物膜形成並殺死附著的細菌,進一步解決因細菌抗生素抗藥性引起的術後感染病例激增的問題。根據世界衛生組織的數據,低收入和中等收入國家約 11% 的患者會受到術後手術部位感染 (SSI) 的影響。它們是由於切口部位或部位內軟組織中生物膜的形成而引起的。此外,慢性病和手術發生率的不斷上升,加上全球老年人口的不斷擴大,正在推動市場的成長。
複絲佔業界最大佔有率
報告還提供了基於材料的詳細市場細分和分析。這包括單絲和複絲。報告稱,複絲佔據最大的市場佔有率。
手術縫合線市場中的複絲細分市場是由對具有增強的靈活性和操作特性的縫合線的需求不斷成長所推動的,特別是在需要精確打結的精密外科手術中。此外,製造技術的進步使得多絲縫合線的生產能夠提高拉伸強度並減少組織創傷,從而提高了外科醫生對它們的採用率。此外,全球範圍內慢性疾病的日益流行和外科手術數量的增加正在推動對多絲縫合線的需求,因為與單絲替代品相比,它們可以更好地閉合傷口並降低感染風險。此外,由於對患者舒適度和術後恢復速度的日益關注,XYZ 部分正在見證成長,因為多絲縫合線通常與減少組織反應和發炎有關,從而改善癒合結果。
心血管手術代表領先的細分市場
該報告根據應用程式提供了詳細的市場細分和分析。這包括心血管手術、普通手術、婦科手術、骨科手術、眼科手術等。根據該報告,心血管手術佔最大部分。
手術縫合線市場中的心血管手術部分是由全球心血管疾病盛行率不斷上升所推動的,因此需要增加手術干預措施來解決這些問題。根據 iData Research 的數據,美國每年進行約 90 萬例心血管手術,預計到 2029 年這一數字將達到 130 萬例。隨著心血管問題的激增,對有效縫合材料的需求不斷增加,以確保最佳傷口閉合和患者康復。此外,包括微創手術在內的外科技術的進步正在推動對專門縫合線的需求,這些縫合線旨在承受心血管手術的獨特挑戰,例如縫合線的高張力和持續壓力。
醫院和診所在市場上表現出明顯的主導地位
報告還提供了基於最終用戶的詳細市場細分和分析。這包括醫院和診所、門診手術中心等。報告顯示,醫院和診所佔據了最大的市場。
由於肥胖和其他慢性病盛行率上升、人口老化以及醫療基礎設施不斷擴大,全球外科手術量不斷增加,推動了醫院業務的發展。根據世界衛生組織的數據,超過 43% 的 18 歲及以上成年人超重,16% 患有肥胖症。醫院需要具有優異抗張強度、結安全性和生物相容性的手術縫合線,以確保最佳傷口閉合併最大限度地減少術後併發症。此外,外科技術的進步和微創手術的採用需要專門的縫合線,以實現精確的組織逼近並促進更快的恢復。根據美國國家醫學圖書館的數據,2017 年約有 980 萬例住院手術室手術,其中約 11.1% 為微創手術,2.5% 為機器人輔助手術。
北美市場領先,佔據最大的手術縫合線市場佔有率
該報告還對所有主要區域市場進行了全面分析,其中包括北美(美國和加拿大);歐洲(德國、法國、英國、義大利、西班牙、俄羅斯等);亞太地區(中國、日本、印度、韓國、澳洲、印尼等);拉丁美洲(巴西、墨西哥等);以及中東和非洲。報告稱,北美是手術縫線最大的區域市場。
北美手術縫合線市場的成長是由不斷成長的醫療保健支出、主要市場參與者的存在以及不斷增加的事故病例所推動的。該地區也得到美國和加拿大的支持。美國擁有多家領先的外科縫合公司,如 Stryker Corporation、Medtronic Plc、Boston Scientific Corporation、Ethicon Inc、Zimmer Biomet Holdings Inc、Teleflex Incorporated 等。根據美國醫院協會 (AHA) 的數據,該國約有 6,090 家醫院。產業消息也顯示,美國每年估計進行 4,830 萬例非手術和外科手術。除了結腸和腸道切除之外,皮膚腫瘤切除、膽囊和膽管樹治療以及疝氣修復是一般外科醫生最常見的外科手術。
(請注意,這只是關鍵參與者的部分列表,報告中提供了完整列表。)
The global surgical sutures market size reached US$ 5.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 8.3 Billion by 2032, exhibiting a growth rate (CAGR) of 5.3% during 2024-2032. Development of advanced suture materials, rapid technological advancements, shifting consumer preference towards minimally invasive surgeries (MIS), inflating consumer per capita income, and burgeoning prevalence of cosmetic surgeries are some of the factors bolstering the market growth.
Escalating chronic diseases prevalence
Globally, the prevalence of chronic diseases in increasing at an unprecedented rate, which has further burgeoned the demand for surgical sutures. As pe the World Health Organization (WHO), about 41 million people die of non-communicable diseases every year, which is equivalent to 74% of all the deaths globally. The escalating prevalence of obesity, diabetes, cardiovascular ailments, and cancers have surged the requirement for surgical interventions, which is further stimulating the market growth. As per the International Diabetes Federation (IDF), by 2045, about 783 million people will be living with diabetes. As these conditions become more common due to factors like aging populations and lifestyle changes, the demand for surgical procedures escalates. Consequently, there's a heightened need for surgical sutures, essential for closing wounds post-surgery.
Development of advanced suture materials
Recent developments in the surgical sutures market have completely changed the wound closure techniques, which is further supporting the market growth. Key market players are developing modern sutures that are more compatible with the human body in order to minimize the risk of infection and promote fast healing. For instance, in May 2023, a team of engineers from the Massachusetts Institute of Technology (MIT) developed "smart" sutures with the potential to benefit Crohn's disease patients undergoing surgery, and could also have applications for drug delivery, sensing inflammation, and cell therapies. These advancements help to improve patient outcomes and also cater to the evolving needs of surgeons, marking a significant leap forward in surgical care.
Burgeoning prevalence of cosmetic surgeries
The inflating consumer per capita income has considerably surged the need to seek aesthetic enhancements, further boosting the demand for cosmetic surgeries, which represents the primary factor propelling the market growth. As per the International Society of Aesthetic Plastic Surgery (ISAPS) in 2020, over 24 million non-surgical and surgical aesthetic procedures were performed globally in 2019. Aesthetic procedures require most precision, which has further burgeoned the requirement for high-quality suture materials to optimal aesthetic outcomes and ensure minimal scarring. The burgeoning cosmetic industry, fueled by societal pressures, media influence, and the desire for self-improvement, has led to a surge in surgical interventions.
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on type, material, application, and end user.
Absorbable sutures accounts for the majority of the market share
The report has provided a detailed breakup and analysis of the market based on the type. This includes absorbable sutures and non-absorbable sutures. According to the report, absorbable sutures represented the largest segment.
The absorbable sutures segment is driven by the increasing demand for minimally invasive surgical procedures and the rising preference for absorbable materials due to their ability to break down harmlessly in the body over time, eliminating the need for suture removal. Additionally, advancements in technology leading to the development of absorbable sutures with enhanced tensile strength, flexibility, and biocompatibility further fuel the growth of this segment. For instance, in May 2023, a new nanocomposite coating was developed that can inhibit biofilm formation and also kill attached bacteria, further tackling the surging cases of post-operative infections, caused due to antibiotic resistance in bacteria. As per the WHO, post-operative surgical site infections (SSIs) affect about 11% of patients in low and middle-income countries. They are caused due to the development of biofilms on the incision site or in the soft tissue inside the site. Moreover, the growing incidence of chronic diseases and surgeries, coupled with the expanding geriatric population globally, are propelling the market growth.
Multifilament holds the largest share of the industry
A detailed breakup and analysis of the market based on the material have also been provided in the report. This includes monofilament and multifilament. According to the report, multifilament accounted for the largest market share.
The multifilament segment in the surgical sutures market is driven by the increasing demand for sutures with enhanced flexibility and handling characteristics, particularly in delicate surgical procedures where precise knot tying is essential. Additionally, advancements in manufacturing technologies have allowed for the production of multifilament sutures with improved tensile strength and reduced tissue trauma, thereby boosting their adoption among surgeons. Moreover, the growing prevalence of chronic diseases and the rising number of surgical procedures worldwide are propelling the demand for multifilament sutures, as they offer better wound closure and reduced risk of infection compared to monofilament alternatives. Furthermore, the XYZ segment is witnessing growth due to the escalating focus on patient comfort and faster postoperative recovery, as multifilament sutures are often associated with reduced tissue reaction and inflammation, leading to improved healing outcomes.
Cardiovascular Surgeries represents the leading market segment
The report has provided a detailed breakup and analysis of the market based on the application. This includes cardiovascular surgeries, general surgeries, gynecological surgeries, orthopedic surgeries, ophthalmic surgeries, and others. According to the report, cardiovascular surgeries represented the largest segment.
The cardiovascular surgeries segment in the surgical sutures market is driven by the increasing prevalence of cardiovascular diseases globally, necessitating a rise in surgical interventions to address these conditions. As per the iData Research, about 900,000 cardiovascular procedures were carried out each year in the United States, and the number is projected to reach 1.3 million by 2029. With the growing aging population and lifestyle factors such as unhealthy diets and sedentary lifestyles contributing to the surge in cardiovascular issues, there's a heightened demand for effective suturing materials to ensure optimal wound closure and patient recovery. Additionally, advancements in surgical techniques, including minimally invasive procedures, are fueling the demand for specialized sutures designed to withstand the unique challenges of cardiovascular surgeries, such as high tension and continuous stress on the sutures.
Hospitals and clinics exhibits a clear dominance in the market
A detailed breakup and analysis of the market based on the end user have also been provided in the report. This includes hospitals and clinics, ambulatory surgical centers, and others. According to the report, hospitals and clinics accounted for the largest market share.
The hospitals segment is driven by the increasing volume of surgical procedures performed globally, spurred by rising prevalence of obesity and other chronic diseases, aging population, and expanding healthcare infrastructure. As per the WHO, over 43% of adults aged 18 and above were overweight and 16% were living with obesity. Hospitals demand surgical sutures characterized by superior tensile strength, knot security, and biocompatibility to ensure optimal wound closure and minimize post-operative complications. Moreover, advancements in surgical techniques and the adoption of minimally invasive procedures necessitate specialized sutures that enable precise tissue approximation and facilitate faster recovery. As per the National Library of Medicine, in 2017 about 9.8 million inpatient operating room procedures were conducted, from which about 11.1% of these procedures were minimally invasive and 2.5% were robotic-assisted.
North America leads the market, accounting for the largest surgical sutures market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for surgical sutures.
The North America surgical sutures market growth is driven by the burgeoning healthcare expenditure, presence of key market players, and the rising cases of accidents. The region is also backed by the presence of the United States and Canada. The United States has a robust presence of several leading surgical suture companies, such as Stryker Corporation, Medtronic Plc, Boston Scientific Corporation, Ethicon Inc, Zimmer Biomet Holdings Inc, Teleflex Incorporated, and others. As per the American Hospital Association (AHA), the country has around 6,090 hospitals. Industry sources also show that every year, an estimated 48.3 million non-surgical and surgical procedures are performed in the United States. Skin tumor excision, gallbladder and biliary tree treatments, and hernia repairs, in addition to colon and intestine resections, are some of the most common surgical procedures performed by general surgeons.
(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)